UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11868) 11868
Newsletter (283) 283
Book Chapter (202) 202
Newspaper Article (86) 86
Magazine Article (51) 51
Dissertation (42) 42
Book / eBook (17) 17
Publication (14) 14
Conference Proceeding (12) 12
Reference (6) 6
Web Resource (4) 4
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10100) 10100
science & technology (5058) 5058
life sciences & biomedicine (4852) 4852
male (3582) 3582
female (3014) 3014
burkitt lymphoma - pathology (2976) 2976
biological and medical sciences (2858) 2858
child (2492) 2492
burkitt's lymphoma (2321) 2321
medical sciences (2299) 2299
burkitt lymphoma (2275) 2275
burkitt lymphoma - genetics (2075) 2075
adult (1947) 1947
oncology (1867) 1867
animals (1818) 1818
burkitt lymphoma - immunology (1809) 1809
adolescent (1803) 1803
cell line (1695) 1695
child, preschool (1646) 1646
burkitt lymphoma - drug therapy (1489) 1489
hematology (1481) 1481
abridged index medicus (1464) 1464
hematologic and hematopoietic diseases (1314) 1314
lymphoma (1251) 1251
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (1250) 1250
middle aged (1209) 1209
tumor cells, cultured (1169) 1169
burkitt lymphoma - diagnosis (1081) 1081
mice (1034) 1034
burkitt lymphoma - metabolism (936) 936
cancer (846) 846
herpesvirus 4, human - immunology (761) 761
hemic and lymphatic diseases (739) 739
aged (736) 736
translocation, genetic (726) 726
burkitt lymphoma - complications (709) 709
tumors (699) 699
herpesvirus 4, human - genetics (688) 688
infant (679) 679
research (656) 656
cell line, tumor (652) 652
fundamental and applied biological sciences. psychology (645) 645
burkitt lymphoma - epidemiology (638) 638
antineoplastic combined chemotherapy protocols - therapeutic use (636) 636
base sequence (619) 619
lymphomas (616) 616
burkitt lymphoma - therapy (599) 599
apoptosis (590) 590
epstein-barr virus (586) 586
burkitt lymphoma - etiology (584) 584
burkitt lymphoma - microbiology (581) 581
burkitt lymphoma - virology (568) 568
immunology (561) 561
prognosis (554) 554
chemotherapy (547) 547
molecular sequence data (547) 547
research article (516) 516
biochemistry & molecular biology (511) 511
pediatrics (499) 499
diagnosis, differential (493) 493
cell biology (474) 474
b-lymphocytes - immunology (458) 458
pathology (452) 452
infectious diseases (448) 448
gene expression (424) 424
viruses (418) 418
leukemia (413) 413
flow cytometry (406) 406
fluorescent antibody technique (405) 405
health aspects (403) 403
treatment outcome (389) 389
pharmacology. drug treatments (377) 377
antineoplastic agents (373) 373
herpesvirus 4, human (371) 371
cells, cultured (367) 367
aids/hiv (366) 366
genetic aspects (356) 356
virology (355) 355
herpesvirus 4, human - isolation & purification (354) 354
time factors (348) 348
polymerase chain reaction (347) 347
retrospective studies (347) 347
non-hodgkin's lymphomas (345) 345
karyotyping (332) 332
care and treatment (328) 328
microbiology (323) 323
biopsy (316) 316
apoptosis - drug effects (315) 315
immunophenotyping (306) 306
viral diseases (305) 305
analysis (303) 303
burkitt lymphoma - mortality (297) 297
diagnosis (296) 296
proteins (296) 296
immune system diseases (289) 289
children (285) 285
transfection (284) 284
lymphocytes (283) 283
chromosome aberrations (278) 278
mutation (276) 276
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11760) 11760
Japanese (245) 245
French (189) 189
Chinese (181) 181
German (104) 104
Russian (93) 93
Spanish (79) 79
Polish (54) 54
Portuguese (23) 23
Italian (18) 18
Hungarian (16) 16
Czech (14) 14
Dutch (14) 14
Hebrew (12) 12
Finnish (8) 8
Korean (8) 8
Croatian (7) 7
Turkish (7) 7
Danish (4) 4
Bulgarian (3) 3
Norwegian (3) 3
Serbian (3) 3
Greek (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of molecular sciences, ISSN 1661-6596, 09/2018, Volume 19, Issue 9, p. 2475
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Lymphoma | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites | Index Medicus | diffuse large B-cell lymphoma (DLBCL) | chronic lymphocytic leukemia (CLL) | burkitt lymphoma (BL) | gene regulation | circular RNA | acute lymphoblastic leukemia (ALL) | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM)
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 327 - 340
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Hematologic and hematopoietic diseases | Infectious diseases | Investigative techniques, diagnostic techniques (general aspects) | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Index Medicus | high-grade B-cell lymphoma | diffuse large B-cell lymphoma | cytogenetics
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9822, pp. 1234 - 1244
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | General aspects | Infectious diseases | Viral diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Transcriptional Activation - genetics | Prognosis | HIV Infections - epidemiology | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Child, Preschool | Infant | Burkitt Lymphoma - epidemiology | Incidence | Endemic Diseases | Malaria - epidemiology | Burkitt Lymphoma - genetics | Epstein-Barr Virus Infections - genetics | Child | Burkitt Lymphoma - drug therapy | Epstein-Barr Virus Infections - epidemiology | Poverty - statistics & numerical data | Health Services Accessibility - statistics & numerical data | Burkitt Lymphoma - virology | Cross-Sectional Studies | Epstein-Barr Virus Infections - virology | Risk Factors | Rituximab | Epstein-Barr Virus Infections - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Proto-Oncogene Proteins c-myc - genetics | Translocation, Genetic - genetics | Care and treatment | Immunocompromised host | Patient outcomes | Genetic aspects | Risk factors | Burkitt's lymphoma | Diseases | Causes of | Practice guidelines (Medicine) | Diagnosis | Low income groups | Chemotherapy | Consolidation | Malaria | Human immunodeficiency virus--HIV | Cyclin-dependent kinases | Drug therapy | Epidemiology | Cancer therapies | Cancer | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Clinical cancer research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4212 - 4223
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Agammaglobulinaemia Tyrosine Kinase | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Mutation | Tumors | Cancer | B-cell lymphoma | Index Medicus | patient-derived xenograft | personalized therapy
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article